HUSSMAN STRATEGIC ADVISORS, INC. - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 214 filers reported holding SAGE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.

Quarter-by-quarter ownership
HUSSMAN STRATEGIC ADVISORS, INC. ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$255,192
-56.2%
12,4000.0%0.05%
-54.2%
Q2 2023$583,048
-46.6%
12,400
-52.3%
0.11%
-37.4%
Q1 2023$1,090,960
+10.0%
26,0000.0%0.17%
+5.6%
Q4 2022$991,640
-2.6%
26,0000.0%0.16%
-8.0%
Q3 2022$1,018,000
+21.2%
26,0000.0%0.18%
+21.4%
Q2 2022$840,000
-2.4%
26,0000.0%0.14%
-13.2%
Q1 2022$861,000
-22.2%
26,0000.0%0.17%
-31.3%
Q4 2021$1,106,000
-66.5%
26,000
-65.1%
0.24%
-66.6%
Q3 2021$3,297,000
-22.0%
74,4000.0%0.73%
-17.0%
Q2 2021$4,227,00074,4000.88%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders